Skip to main content
. 2024 Mar;28(Suppl 1):S1–S155. doi: 10.5005/jaypee-journals-10071-24667

Table 5.

Comparison of all parameters between Survivors and Non-Survivors

Parameters Survivors Non-survivors p-value
Age 46.63 ± 11.75 51.62 ± 12.10 0.09 NS
Gender (Male:Female) 20 (48.8%): 21 (51.2%) 21 (72.4%): 8 (27.6%) <0.001 S
SOFA Score 7.44 ±3.02 8.62 ± 3.21 0.13 NS
Apache Score 22.20 ± 7.16 28.45 ± 8.14 <0.001 S
Murray Score 3.50 ± 0.59 3.33 ± 0.70 0.30 NS
Ratio of PaO2 and FiO2 66.69 ± 16.63 75.63 ± 21.93 0.07 NS
Vasoactive inotropic score 147.00 ± 81.23 205.16 ± 72.46 <0.001 S
Co-morbidities
HTN 13 (31.7%) 9 (31.0%) 0.18 NS
DM 14 (34.1%) 12 (41.4%) 0.65 NS
CAD 6 (14.6%) 5 (17.2%) 0.69 NS
PLD 3 (7.3%) 5 (17.2%) 0.029 S
Days on Ventilation before ECMO 2.93 ± 1.49 4.34 ± 2.19 <0.001 S
Duration of ECMO 18.07 ± 11.51 13.91 ± 7.22 0.07 NS
MV 24.66 ± 15.26 17.90 ± 8.29 0.02 S
LOS in ICU 26.29 ± 13.56 18.97 ± 8.65 <0.01 S
LOS in Hospital 31.49 ± 16.03 21.45 ± 9.25 <0.001 S
Complications
Bleeding 10 (24.4%) 10 (34.5%) 0.08 NS
Sepsis 13 (31.7%) 27 (93.1%) <0.001 S
Circuit Change 3 (7.3%) 1 (3.4%) 0.19 NS
Barotrauma 2 (4.9%) 2 (6.9%) 0.54 NS
Stroke 4 (66.66%) 2 (33.33%) 0.83 NS